ArticleBrain communications2026
Motor tract lesion mapping from the brain to the lower spinal cord in people with relapsing-remitting multiple sclerosis: exploring the association between lesion severity and functional consequences by limb.
Article in Brain communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motor deficits in people with multiple sclerosis (pwMS) are often asymmetrical, suggesting an important role of focal lesions affecting the corresponding motor pathways. However, only a modest relationship has been established between lesion load and physical disability. One hypothesis could be that only heavily demyelinated lesions along the corticospinal tract (CST) would be associated with functional consequences. To test this hypothesis, we reconstructed the whole CST from the cortex to the bottom of the spinal cord and linked its structural damage with its functional consequences as measured clinically [with the American Spinal Injury Association motor (mASIA) score] and electrophysiologically [with the central motor conduction time (CMCT)] by limb. We prospectively included 60 relapsing-remitting pwMS and 33 healthy controls. The CSTs were reconstructed using probabilistic atlases. Lesion volume fraction and myelin content [approximated through the magnetization transfer ratio (MTR) and quantitative T1 (qT1)] were calculated by side on the different portions of the CST. Voxelwise MTR z-score maps were also produced to detect lesions severely demyelinated (z-score < -1.96 SD) along the whole CST. Forty-six pwMS and 28 healthy controls were included in the analyses. In the upper limb, CMCT was associated with both cervical lesion load (P < 0.001) and cervical MTR (P = 0.02) in the CST. In the lower limb, CMCT was associated with cervical lesion load and brain and thoracic MTR (all P < 0.001) in the CST. The Expanded Disability Status Scale score was associated with brainstem lesion load and thoracic MTR (all P < 0.01) in the CST. No association was found with the mASIA score per limb. Twenty-six per cent of the lesions were classified as severe, mainly in the cervical CST. In patients with at least one severe lesion, extra-lesional MTR along the CST was lower than in those without severe lesions (P < 0.001). The presence of a severe lesion in the spinal cord CST was the only explanatory variable associated with an increased risk of having an abnormal lower limb CMCT (odds ratio [95% confidence interval]: 1.74 [1.36-2.24], P < 0.001). The main results were replicated with qT1. In this study, we describe varying levels of microstructural damage in lesions along the CST, with associations observed between lesion severity and both extra-lesional damage and CMCT. These findings highlight the critical role of severe lesions along the CST-particularly at the cervical level-beyond overall lesion load, and underscore the need to develop therapies that promote remyelination and to evaluate their effects at the cervical spinal cord level.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.